Metraipolis › archive › dc_f0f8c548b368
Trimester-Specific Blood Trihalomethane and Urinary Haloacetic Acid Concentrations and Adverse Birth Outcomes: Identifying Windows of Vulnerability during… — Europe PMC PMID:33026246
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33026246
- DOI
- 10.1289/ehp7195
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T09:08:06.447Z
- SHA-256 of the archived text
5a247128fe4e83f0d43474780fede117496f9d6772b4c0be09332da500aac4c8- Stable URL of this page
https://metraipolis.com/documento/dc_f0f8c548b368
How to cite
Trimester-Specific Blood Trihalomethane and Urinary Haloacetic Acid Concentrations and Adverse Birth Outcomes: Identifying Windows of Vulnerability during… — Europe PMC PMID:33026246 — Europe PMC (en), https://europepmc.org/article/MED/33026246 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f0f8c548b368 (Metraipolis archive dc_f0f8c548b368, sha256 5a247128fe4e83f0d43474780fede117496f9d6772b4c0be09332da500aac4c8)
BibTeX
@misc{dcf0f8c548b368,
title = {Trimester-Specific Blood Trihalomethane and Urinary Haloacetic Acid Concentrations and Adverse Birth Outcomes: Identifying Windows of Vulnerability during… — Europe PMC PMID:33026246},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33026246},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f0f8c548b368; sha256 5a247128fe4e83f0d43474780fede117496f9d6772b4c0be09332da500aac4c8},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33026246. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Some disinfection by-products (DBPs) are reproductive and developmental toxicants in laboratory animals. However, studies of trimester-specific DBP exposure on adverse birth outcomes in humans are inconsistent. Objective: We examined whether trimester-specific blood and urinary biomarkers of DBP were associated with small for gestational age (SGA), low birth weight (LBW), and preterm birth. Methods: A total of 4,086 blood and 3,951 urine samples were collected across pregnancy trimesters among 1,660 mothers from Xiaogan City, China. Blood samples were quantified for biomarkers of trihalomethanes (THMs): chloroform (TCM), bromodichloromethane, dibromochloromethane, and bromoform. Urine samples were quantified for biomarkers of haloacetic acids (HAA): dichloroacetic acid and trichloroacetic acid. Birth outcomes were abstracted at delivery from medical records. We used Poisson regression models with log link functions to estimate risk ratios (RRs) and 95% confidence intervals (CIs) for SGA, LBW, and preterm birth across tertiles (or categories) of DBP biomarker concentrations measured across pregnancy trimesters. We also examined the relative exposure differences across gestation comparing adverse outcomes with normal births using mixed-effects models. Results: Blood TCM concentrations in the second trimester were associated with an elevated risk of SGA comparing middle vs. lowest (RR, 2.34; 95% CI: 1.02, 5.35) and highest vs. lowest (RR, 2.47; 95% CI: 1.09, 5.58) exposure groups. Third-trimester blood TCM concentrations were also associated with an increased risk of SGA comparing the second tertile with the first (RR, 2.61; 95% CI: 1.15, 5.92). We found that maternal blood TCM concentrations were significantly higher for SGA compared with non-SGA births across the period from 23 to 34 wk gestation. Other blood and urinary DBP biomarkers examined were unrelated to SGA, LBW, or preterm birth. Conclusion: Blood TCM concentrations in mid to late pregnancy were associated with an increased risk of SGA, whereas other biomarkers of DBPs examined across pregnancy were not associated with birth outcomes. https://doi.org/10.1289/EHP7195. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2020 (prima pubblicazione 2020-10-07). Identificativi: PMID 33026246 · PMCID PMC7539675 · DOI 10.1289/ehp7195. Pagina: https://europepmc.org/article/MED/33026246 — https://doi.org/10.1289/ehp7195. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T09:03:55.919Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.